Works at @DDNewsLive. Covers #Health, #Publicpolicy, #Socialissues, #Travel, #Foodie @IIMC alum RT is not endorsement. Tweets personal.
New Delhi
Joined February 2012
- Tweets61.5K
- Following1.6K
- Followers3.4K
- Likes79.2K
Nitendra Singh नितेन्द्र सिंह retweeted
PM @narendramodi greets nation on Govardhan Puja, wishing everyone peace, happiness and prosperity.
#GovardhanPuja
Nitendra Singh नितेन्द्र सिंह retweeted
"अज्ञानता और विचारहीनता मानवता के विनाश के दो सबसे बड़े कारण हैं।" - जॉन टिलोटसन
#goodmorning
जय श्री महाकाल 🙏
ॐ श्री महाकालेश्वराय नमः 🙏🏻
दिनांक 10 नवंबर 2026 को ज्योतिर्लिंग भगवान श्री महाकालेश्वर जी का प्रातः कालीन भस्म आरती श्रृंगार दर्शन
#mahakal #ujjain #ujjainlive #harharmahadev
1
37
"अज्ञानता और विचारहीनता मानवता के विनाश के दो सबसे बड़े कारण हैं।" - जॉन टिलोटसन
#goodmorning
"Ignorance and inconsideration are the two great causes of the ruin of mankind. " - John Tillotson
#goodmorning
27
Nitendra Singh नितेन्द्र सिंह retweeted
बाल विवाह के खिलाफ मोदी सरकार की मुहिम, 2030 तक भारत को इस कुप्रथा से मुक्त करने का लक्ष्य
🔗: ddnews.gov.in/modi-governmen…
Nitendra Singh नितेन्द्र सिंह retweeted
#Delhi | Nearly 110 patients presented on Diwali (8-11-2026) and the early hours of the next day (9-11-2026) to Eye casualty services, Dr Rajendra Prasad Centre for Ophthalmic Sciences, @aiims_newdelhi, with majority of patients suffering from fire-cracker related ocular injuries.
A total of 72 patients had non-sight-threatening injuries and were managed conservatively. A total of 18 patients had corneal perforations and lacerations and underwent surgical intervention in the emergency operation theatre. In addition, 20 more patients are planned for surgical intervention today for fire-cracker related ocular injuries. Majority of patients were children and young.
Nitendra Singh नितेन्द्र सिंह retweeted
कैंसर की 1,364 दवाओं की कीमतों में भारी कटौती, आज से नई दरें लागू; मरीजों को सालाना 3,540 करोड़ रुपए की बचत
ddnews.gov.in/drastic-price-…
दीपावली पर पटाखों से आंखों में चोट के करीब 110 मामले AIIMS में पहुंचे
नई दिल्ली स्थित अखिल भारतीय आयुर्विज्ञान संस्थान (AIIMS) के डॉ. राजेंद्र प्रसाद नेत्र विज्ञान केंद्र की इमरजेंसी सेवाओं में दीपावली के दिन (8 नवंबर 2026) और अगले दिन सुबह (9 नवंबर 2026) तक करीब 110 मरीज आंखों में चोट की शिकायत लेकर पहुंचे। इनमें से अधिकांश मरीज पटाखों के कारण आंखों में लगी चोट से पीड़ित थे।
इनमें से 72 मरीजों को ऐसी चोटें आई थीं, जिनसे उनकी आंखों की रोशनी को तत्काल कोई खतरा नहीं था। इन मरीजों का बिना सर्जरी के दवाओं और अन्य उपचार के जरिए इलाज किया गया।
वहीं, 18 मरीजों की आंखों में कॉर्निया (पुतली के पारदर्शी हिस्से) में छेद और कटने जैसी गंभीर चोटें पाई गईं। इन सभी मरीजों की इमरजेंसी ऑपरेशन थिएटर में सर्जरी की गई।
इसके अलावा, पटाखों से आंखों में लगी चोट के 20 अन्य मरीजों की सर्जरी आज की जानी प्रस्तावित है। घायलों में अधिकांश बच्चे और युवा शामिल हैं।
Nearly 110 patients presented on Diwali (8-11-2026) and the early hours of the next day (9-11-2026) to Eye casualty services, Dr Rajendra Prasad Centre for Ophthalmic Sciences, AlIMS, New Delhi, with majority of patients suffering from fire-cracker related ocular injuries.
A total of 72 patients had non-sight-threatening injuries and were managed conservatively. A total of 18 patients had corneal perforations and lacerations and underwent surgical intervention in the emergency operation theatre. In addition, 20 more patients are planned for surgical intervention today for fire-cracker related ocular injuries. Majority of patients were children and young
Nearly 110 patients presented on Diwali (8-11-2026) and the early hours of the next day (9-11-2026) to Eye casualty services, Dr Rajendra Prasad Centre for Ophthalmic Sciences, AlIMS, New Delhi, with majority of patients suffering from fire-cracker related ocular injuries.
A total of 72 patients had non-sight-threatening injuries and were managed conservatively. A total of 18 patients had corneal perforations and lacerations and underwent surgical intervention in the emergency operation theatre. In addition, 20 more patients are planned for surgical intervention today for fire-cracker related ocular injuries. Majority of patients were children and young
Nitendra Singh नितेन्द्र सिंह retweeted
#Delhi | Safdarjung Hospital Records 135 Diwali-Related Burn Injury Cases Over Two Days
Vardhman Mahavir Medical College & Safdarjung Hospital recorded 135 Diwali-related burn injury cases at its Burns Emergency during 7–8 November 2026.
Of these, 129 cases were caused by firecracker-related injuries, while 6 were related to diya burns.
Among the patients reporting with Diwali-related injuries, 35 children sustained firecracker-related injuries and were treated in the OPD, while one child required hospital admission.
@SJHDELHI #Diwali #Diwali2026
Nitendra Singh नितेन्द्र सिंह retweeted
The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs, based on the recommendations of an Expert Committee constituted by the Directorate General of Health Services (DGHS), Ministry of Health & Family Welfare, on 17th October, 2026.
The revised MRPs of these medicines come into effect from today, 9th November, 2026.
@Pharmadept
Nitendra Singh नितेन्द्र सिंह retweeted
The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs, based on the recommendations of an Expert Committee constituted by the Directorate General of Health Services (DGHS), Ministry of Health & Family Welfare, on 17th October, 2026. The revised MRPs of these medicines come into effect from today, 9th November.
As on 8th of November, 85 Pharmaceutical Companies have reported revised MRPs for 1,364 anti-cancer formulations, covering 121 drugs. With 679 brands reporting price reductions of more than 50%. The highest reported reduction in MRP is 96.45%. As a result of the price reductions the estimated annual savings to consumers is expected to be ₹3,540.38 crore.
Consumers can check the revised MRP printed on the medicine pack and verify medicine prices through the Pharma Sahi Daam mobile app or NPPA website (nppa.gov.in). No chemist or hospital pharmacy can charge more than the revised MRP. In case of overcharging or any other pricing-related complaint, consumers can register their grievance through the Pharma Jan Samadhan portal or contact the NPPA helpline at 1800-111-255.
🔗pib.gov.in/PressReleaseDetai…
@PIB_India
Nitendra Singh नितेन्द्र सिंह retweeted
#LiveAt11 | Government has introduced major pricing reforms to make cancer treatment more affordable across India. Trade margins on 137 non-scheduled cancer drugs have been capped at 30%, while prices of 543 branded and patented medicines have been revised, bringing down costs by 20–70%, with some medicines seeing reductions of up to 96%. The revised rates are mandatory across public and private hospitals and retail pharmacies, aiming to ease patients' financial burden and improve access to life-saving treatment.
#CancerCare #AffordableHealthcare #CancerTreatment #11बजेLive #11बजेLiveOnDD
Nitendra Singh नितेन्द्र सिंह retweeted
बेवासिज़ुमैब 100 mg इंजेक्शन, फेफड़े, आंत, अंडाशय और गर्भाशय-ग्रीवा के कैंसर में प्रयुक्त।
प्रमुख ब्रांडों की संशोधित MRP: ₹3,103 से ₹3,985, पहले ₹7,686 से ₹25,995।
कैंसर की दवाइयों की संशोधित MRP आज से लागू।
#AffordableCancerCare
Nitendra Singh नितेन्द्र सिंह retweeted
केंद्र सरकार ने कैंसर के इलाज को किफायती बनाने की दिशा में एक ऐतिहासिक कदम उठाते हुए कैंसर की 543 ब्रांडेड दवाओं की संशोधित कीमतें और 137 गैर-अनुसूचित दवाओं पर 30% ट्रेड मार्जिन की सीमा लागू कर दी है।
#CancerCare #Healthcare #ModiGovernment #AffordableMedicine
Nitendra Singh नितेन्द्र सिंह retweeted
एबिराटेरोन एसीटेट 250 mg, प्रोस्टेट कैंसर में प्रयुक्त।
एक ब्रांड: ₹41,250 → ₹3,218 प्रति पैक। चार प्रमुख ब्रांड अब ₹3,218 से ₹5,768 के बीच, पहले ₹28,744–₹41,250।
कैंसर की दवाइयों की संशोधित MRP आज से लागू।
#AffordableCancerCare
Nitendra Singh नितेन्द्र सिंह retweeted
#11BajeLive | केंद्र सरकार द्वारा कैंसर के इलाज को किफायती बनाने के लिए एक ऐतिहासिक कदम उठाया गया है!
आज से कैंसर की 543 ब्रांडेड दवाओं की संशोधित कीमतें और 137 गैर-अनुसूचित दवाओं पर अधिकतम 30% ट्रेड मार्जिन की सीमा लागू हो गई है।
🔗youtu.be/auEcTb1WAN0
#CancerCare #AffordableMedicine #HealthcareForAll
The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs, based on the recommendations of an Expert Committee constituted by the Directorate General of Health Services (DGHS), Ministry of Health & Family Welfare, on 17th October, 2026. The revised MRPs of these medicines come into effect from today, 9th November, 2026.
As on 8th of November, 2026, 85 Pharmaceutical Companies have reported revised MRPs for 1,364 anti-cancer formulations, covering 121 drugs. With 679 brands reporting price reductions of more than 50%. The highest reported reduction in MRP is 96.45%. As a result of the price reductions the estimated annual savings to consumers is expected to be ₹3,540.38 crore.
Consumers can check the revised MRP printed on the medicine pack and verify medicine prices through the Pharma Sahi Daam mobile app or NPPA website (nppa.gov.in). No chemist or hospital pharmacy can charge more than the revised MRP. In case of overcharging or any other pricing-related complaint, consumers can register their grievance through the Pharma Jan Samadhan portal or contact the NPPA helpline at 1800-111-255.
70